Professor Dame Molly Stevens
John Black Professor of Bionanoscience, University of Oxford
How can discoveries made in the lab genuinely benefit patients?
In biomedical engineering, new technologies are transforming what is possible, from brain-computer interfaces and AI-assisted clinical decision support to cell and gene therapies and lab-grown tissues. Research conducted in The Stevens Group explores the interface between material science and biology to develop new approaches to disease detection, drug delivery and regenerative medicine.
Discoveries should reach patients
Yet, scientific discovery is only the beginning. The next challenge is translating those discoveries into technologies that improve patients’ lives. Translation requires more than excellent science. It depends on collaboration across disciplines, from researchers and clinicians to engineers, entrepreneurs, industry and patients. It requires an environment where ideas can move between laboratory, clinic and company, plus investors who are prepared to take the risks needed to turn promising discoveries into practical solutions.
Initiatives such as London Life Sciences Week bring the world’s life sciences community to the UK,
creating space to share ideas,
build partnerships and accelerate the journey from breakthrough science to patient benefit
The UK research advantage
The UK has extraordinary strengths in these areas, including world-leading universities, hospitals, investors, innovators and life sciences companies. The UK is home to one of the world’s leading life sciences ecosystems; we have attracted more than £3 billion in new public-private investment in the past 12 months and have the most startup companies of any European country. Oxford-London-Cambridge is particularly well positioned, bringing many of these capabilities together in close proximity, thereby creating opportunities for ideas and expertise to connect.
Maintaining this advantage requires careful cultivation. Initiatives such as London Life Sciences Week bring the world’s life sciences community to the UK, creating space to share ideas, build partnerships and accelerate the journey from breakthrough science to patient benefit.
